Acción 300430 BEIJING CHIEFTAIN CONTROL ENGINEERING TECHNOLOGY CO., LTD.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Beijing Chieftain Control Engineering Technology Co., Ltd.

Acciones

300430

CNE100001YS5

Precio de cierre Shenzhen S.E.
Otros sitios de cotización
 00:00:00 26/04/2024 		Varia. Cinco días. Varia. 1 de enero.
18,06 CNY +6,30 % Gráfico intradía de Beijing Chieftain Control Engineering Technology Co., Ltd. +16,29 % +26,38 %
21/04 Beijing Chieftain Control Engineering Technology Co. presenta los resultados del ejercicio cerrado el 31 de diciembre de 2023 CI
2023 Beijing Chieftain Control Engineering Technology Co. informa de los resultados de los nueve meses finalizados el 30 de septiembre de 2023 CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
Beijing Chieftain Control Engineering Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Beijing Chieftain Control Engineering Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Beijing Chieftain Control Engineering Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Beijing Chieftain Control Engineering Technology Co., Ltd. Announces 2022 Final Profit Distribution Plan to Be Implemented (A Shares), Payment Date 12 July 2023
Beijing Chieftain Control Engineering Technology Co., Ltd. Approves Cash Dividend for the Year 2022
Beijing Chieftain Control Engineering Technology Co., Ltd. Proposes Final Cash Dividend for the Year 2022
Beijing Chieftain Control Engineering Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Beijing Chieftain Control Engineering Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong completed the acquisition of a 99.22% stake in Ningxia EPPEN Biotech Co.,ltd from a group of sellers.
Beijing Chieftain Control Engineering Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
Beijing Chieftain Control Engineering Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
Beijing Chieftain Control Engineering Technology Co., Ltd. Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares), Payment Date: 08 July 2022
Beijing Chieftain Control Engineering Technology Co., Ltd. Approves Cash Dividend for 2021
Beijing Chieftain Control Engineering Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
Beijing Chieftain Control Engineering Technology Co., Ltd. Proposes Final Cash Dividend for the Year 2021
Beijing Chieftain Control Engineering Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong signed a Letter of Intent to acquire a 99.22% stake in Ningxia EPPEN Biotech Co.,ltd from a group of sellers for approximately CNY 5.376 billion.
Guangzhou Longzhijie Technology Co., Ltd. announced that it expects to receive CNY 90 million in funding from Beijing Chieftain Control Engineering Technology Co., Ltd.
Beijing Chieftain Control Engineering Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
Tranche Update on Beijing Chieftain Control Engineering Technology Co., Ltd.'s Equity Buyback Plan announced on February 8, 2021.
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción 300430
  4. Noticias Beijing Chieftain Control Engineering Technology Co., Ltd.
  5. Otros idiomas